The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target (vol 30, pg 726, 2022)

被引:0
|
作者
Verma, Ankit
Pittala, Srinivas
Alhozeel, Belal
Shteinfer-Kuzmine, Anna
Ohana, Ehud
Gupta, Rajeev
Chung, Jay H.
Shoshan-Barmatz, Varda
机构
关键词
D O I
10.1016/j.ymthe.2024.03.013
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1178 / 1178
页数:1
相关论文
共 50 条
  • [21] Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease
    Wu, Meng
    Pei, Zhiyin
    Long, Guangfeng
    Chen, Hongbing
    Jia, Zhanjun
    Xia, Weiwei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [22] LRG1 as a novel therapeutic target in eye disease (vol 36, pg 328, 2022)
    De Rossi, Giulia
    Da Vitoria Lobo, Marlene E.
    Greenwood, John
    Moss, Stephen E.
    EYE, 2023, 37 (07) : 1517 - 1517
  • [23] An Integrated Taxonomy for Monogenic Inflammatory Bowel Disease (vol 162, pg 859, 2022)
    Bolton, Chrissy
    Smillie, Christopher S.
    Pandey, Sumeet
    Elmentaite, Rasa
    Wei, Gabrielle
    Argmann, Carmen
    Aschenbrenner, Dominik
    James, Kylie R.
    McGovern, Dermot P. B.
    Macchi, Marina
    Cho, Judy
    Shouval, Dror S.
    Kammermeier, Jochen
    Koletzko, Sibylle
    Bagalopal, Krithika
    Capitani, Melania
    Cavounidis, Athena
    Pires, Elisabete
    Weidinger, Carl
    McCullagh, James
    Arkwright, Peter D.
    Haller, Wolfram
    Siegmund, Britta
    Peters, Lauren
    Jostins, Luke
    Travis, Simon P. L.
    Anderson, Carl A.
    Snapper, Scott
    Klein, Christoph
    Schadt, Eric
    Zilbauer, Matthias
    Xavier, Ramnik
    Teichmann, Sarah
    Muise, Aleixo M.
    Regev, Aviv
    Uhlig, Holm H.
    GASTROENTEROLOGY, 2022, 162 (07) : 2143 - 2143
  • [24] VDAC1 as a target in cisplatin anti-tumor activity through promoting mitochondria fusion (vol 560, pg 52, 2021)
    Luo, Lei
    Xiong, Yanyan
    Jiang, Nan
    Zhu, Xueqin
    Lv, Yuan
    Xie, Ying
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 587 : 170 - 170
  • [25] TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control (vol 10, pg 2279, 2014)
    Gatliff, Jemma
    East, Daniel
    Crosby, James
    Abeti, Rosella
    Harvey, Robert
    Craigen, William
    Parker, Peter
    Campanella, Michelangelo
    AUTOPHAGY, 2016, 12 (02) : 442 - 442
  • [26] Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
    Ankit Verma
    Anna Shteinfer-Kuzmine
    Nikita Kamenetsky
    Srinivas Pittala
    Avijit Paul
    Edna Nahon Crystal
    Alberto Ouro
    Vered Chalifa-Caspi
    Swaroop Kumar Pandey
    Alon Monsonego
    Noga Vardi
    Shira Knafo
    Varda Shoshan-Barmatz
    Translational Neurodegeneration, 11
  • [27] Histopathological Features of Monogenic Inflammatory Bowel Disease: Subanalysis of Systematic Review (vol 1, pg 679, 2022)
    不详
    GASTRO HEP ADVANCES, 2024, 3 (02):
  • [28] Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathology
    Verma, Ankit
    Shteinfer-Kuzmine, Anna
    Kamenetsky, Nikita
    Pittala, Srinivas
    Paul, Avijit
    Nahon Crystal, Edna
    Ouro, Alberto
    Chalifa-Caspi, Vered
    Pandey, Swaroop Kumar
    Monsengo, Alon
    Vardi, Noga
    Knafo, Shira
    Shoshan-Barmatz, Varda
    TRANSLATIONAL NEURODEGENERATION, 2022, 11 (01)
  • [29] APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease
    Sahakian, Lauren
    Robinson, Ainsley M.
    Sahakian, Linda
    Stavely, Rhian
    Kelley, Mark R.
    Nurgali, Kulmira
    BIOMOLECULES, 2023, 13 (11)
  • [30] The role of microbial succinate in the pathophysiology of inflammatory bowel disease: mechanisms and therapeutic potential
    Fernandez-Veledo, Sonia
    Grau-Bove, Carme
    Notararigo, Sara
    Huber-Ruano, Isabel
    CURRENT OPINION IN MICROBIOLOGY, 2025, 85